Activity of grepafloxacin and other fluoroquinones and newer macrolides against recent clinical isolates of Chlamydia pneumoniae
- 1 July 1999
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 12 (2) , 181-184
- https://doi.org/10.1016/s0924-8579(99)00057-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- In Vitro Activity of a New 8-Methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniaeAntimicrobial Agents and Chemotherapy, 1998
- The in-vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum and Legionella sppJournal of Antimicrobial Chemotherapy, 1997
- In vitro activity of trovafloxacin against Chlamydia pneumoniaeAntimicrobial Agents and Chemotherapy, 1997
- Antibacterial Activities of Grepafloxacin, Ciprofloxacin, Ofloxacin and FleroxacinJournal of Chemotherapy, 1997
- Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumoniaThe Pediatric Infectious Disease Journal, 1995
- In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniaeAntimicrobial Agents and Chemotherapy, 1994
- In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1993
- In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniaeAntimicrobial Agents and Chemotherapy, 1992
- In vitro activities of five quinolones against Chlamydia pneumoniaeAntimicrobial Agents and Chemotherapy, 1992
- A New Respiratory Tract Pathogen: Chlamydia pneumoniae Strain TWARThe Journal of Infectious Diseases, 1990